Search Results - "Suppan, C"

On the microstructure control of the bendability of advanced high strength steels by Suppan, C., Hebesberger, T., Pichler, A., Rehrl, J., Kolednik, O.

“…The formability of newly developed steel grades is a key parameter for their successful implementation in the car body. In the present work, the influence of…”
Get full text

Fracture Resistance of Advanced High-Strength Steel Sheets for Automotive Applications by Frómeta, D., Lara, A., Grifé, L., Dieudonné, T., Dietsch, P., Rehrl, J., Suppan, C., Casellas, D., Calvo, J.

“…The fracture resistance of different advanced high-strength steel (AHSS) sheets for automotive applications is investigated through conventional tensile tests,…”
Get full text

Microstructural effects on fracture toughness of ultra-high strength dual phase sheet steels by Frómeta, D., Cuadrado, N., Rehrl, J., Suppan, C., Dieudonné, T., Dietsch, P., Calvo, J., Casellas, D.

“…The influence of microstructure on the fracture toughness of two industrially processed 1000 MPa dual-phase (DP) steel grades is investigated. Crack initiation…”
Get full text

On the correlation between fracture toughness and crash resistance of advanced high strength steels by Frómeta, D., Lara, A., Molas, S., Casellas, D., Rehrl, J., Suppan, C., Larour, P., Calvo, J.

“…•A fracture mechanics approach to assess the impact performance of AHSS is presented.•Fracture resistance is evaluated through the essential work of fracture…”
Get full text

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting? by Wimmer, K., Hlauschek, D., Balic, M., Pfeiler, G., Strobl-Kacerovsky, S., Greil, R., Singer, C.F., Halper, S., Steger, G., Suppan, C., Gampenrieder, S.P., Helfgott, R., Egle, D., Filipits, M., Jakesz, R., Sölkner, L., Fesl, C., Gnant, M., Fitzal, F.

Get full text

Changes in ctDNA levels established with the untargeted mFAST-SeqS method reflect response to therapy in metastasized breast cancer patients by Heitzer, E, Auer, M, Suppan, C, Dandachi, N, Balic, M

Get full text

Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis by Suppan, C, Tiran, V, Heitzer, E, Auer, M, Cote, R.J, Datar, R.H, Dandachi, N, Balic, M

Get full text

OC-0345: Assessment of improved organ at risk sparing for meningioma for mixed or single photon and particle beam treatments by Knäusl, B, Mock, U, Sölkner, L, Suppan, C, Dieckmann, K, Georg, D

Get full text

2261P A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2- breast cancer patients by Dandachi, N., Graf, R., Pancheri, L., Dobrić, N., Klocker, E.V., Suppan, C., Jost, P.J., Heitzer, E., Balic, M.

Get full text

491P Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients by Dobrić, N., Dandachi, N., Klocker, E.V., Suppan, C., Graf, R., Hasenleithner, S., Jost, P.J., Heitzer, E., Balic, M.

Get full text

79P Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients by Suppan, C., Zhou, Q., Graf, R., Klocker, V., Terbuch, A., Dandachi, N., Heitzer, E., Balic, M.

Get full text

886 - Changes in ctDNA levels established with the untargeted mFAST-SeqS method reflect response to therapy in metastasized breast cancer patients by Heitzer, E., Auer, M., Suppan, C., Dandachi, N., Balic, M.

Get full text

320PUntargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment by Balic, M, Suppan, C, Brcic, I, Tiran, V, Mueller, D H, Posch, F, Ulz, P, Heitzer, E, Dandachi, N

“…Abstract Background The aim of this study was to assess the prognostic and predictive value of an untargeted assessment of tumor fractions in the plasma of…”
Get full text

320P - Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment by Balic, M., Suppan, C., Brcic, I., Tiran, V., Mueller, D.H., Posch, F., Ulz, P., Heitzer, E., Dandachi, N.

“…The aim of this study was to assess the prognostic and predictive value of an untargeted assessment of tumor fractions in the plasma of metastatic breast…”
Get full text

Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment by Balic, M., Suppan, C., Brcic, I., Tiran, V., Mueller, D.H., Posch, F., Ulz, P., Heitzer, E., Dandachi, N.

Get full text

The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis by PETTERSSON, Andreas, GRAFF, Rebecca E, SUPPAN, Catherine, FLAVIN, Richard, SESSO, Howard D, RIDER, Jennifer R, SWEENEY, Christopher, STAMPFER, Meir J, FIORENTINO, Michelangelo, KANTOFF, Philip W, SANDA, Martin G, GIOVANNUCCI, Edward L, BAUER, Scott R, DING, Eric L, LODA, Massimo, MUCCI, Lorelei A, PITT, Michael J, LIS, Rosina T, STACK, Edward C, MARTIN, Neil E, KUNZ, Lauren, PENNEY, Kathryn L, LIGON, Azra H

“…Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):v-ets erythroblastosis virus E26 oncogene homolog (ERG) has prognostic value in…”
Get full text

Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment by Suppan, C., Brcic, I., Heitzer, E., Tiran, V., Mueller, H.D., Auer, M., Cote, R.J., Datar, R., Dandachi, N., Balic, M.

Get full text

466 (PB-099) - Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment by Suppan, C., Brcic, I., Heitzer, E., Tiran, V., Mueller, H.D., Auer, M., Cote, R.J., Datar, R., Dandachi, N., Balic, M.

Get full text

249 - Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis by Suppan, C., Tiran, V., Heitzer, E., Auer, M., Cote, R.J., Datar, R.H., Dandachi, N., Balic, M.

Get full text

172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) by Singer, C.F., Egle, D., Greil, R., Öhler, L., Petru, E., Suppan, C., Marhold, M., Pfeiler, G., Brunner, C., Tinchon, C., Halper, S., Galid, A., Pluschnig, U., Haslbauer, F., Hubalek, M., Redl, A., Flatschacher, J., Hennebelle, M., Mraz, B., Bartsch, R.

Get full text